The Metabolic Syndrome, type II Diabetes and Atherosclerosis (MSDA formerly MSAC) congress was created in 2002
in order to gather International experts from different fields to discuss a full spectrum of pertinent topics
relating to metabolic syndrome, diabetes and atherosclerosis.